NSC 743380 induces apoptosis in sensitive cell lines through activation of tyrosine kinase 2 (Tyk2)

被引：0

作者：

Newton, Dianne L. ^{[1
]}

Stockwin, Luke H. ^{[1
]}

Mullendore, Michael E. ^{[1
]}

Han, Bingnan ^{[1
]}

Morrison, Bethanie L. ^{[1
]}

Borgel, Suzanne ^{[2
]}

Stotler, Howard ^{[2
]}

Fang, Bingliang ^{[3
]}

Hollingshead, Melinda G. ^{[4
]}

机构：

[1] NCI, Drug Mech Grp, SAIC Frederick Inc, Frederick, MD 21701 USA

[2] NCI, In Vivo Preclin Support Grp, SAIC Frederick Inc, Frederick, MD 21701 USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA

[4] NCI, Biol Testing Branch, Frederick, MD 21701 USA

来源：

CANCER RESEARCH | 2012年 / 72卷

关键词：

D O I：

10.1158/1538-7445.AM2012-2810

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2810

引用

页数：2

共 50 条

[41] Baseline Biomarkers Predict Better Responses to Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 (TYK2) Inhibitor, in a Phase 2 Trial in Psoriatic Arthritis
FitzGerald, Oliver
Gladman, Dafna
Mease, Philip J.
Ritchlin, Christopher
Smolen, Josef
Gao, Lu
Hu, Sarah
Nowak, Miroslawa
Banerjee, Subhashis
Catlett, Ian M.
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 4229 - 4230
[42] RETRACTED: Identification of Gene-Tyrosine Kinase 2 (TYK2) in Head and Neck Squamous Cell Carcinoma Patients-An Integrated Bioinformatics Approach (Retracted Article)
Gong, Xiaoyan
Ren, Fukai
DISEASE MARKERS, 2022, 2022
[43] A novel highly selective allosteric inhibitor of tyrosine kinase 2 (TYK2) can block inflammation- and autoimmune-related pathways
Celia X.-J. Chen
Wei Zhang
Shulan Qu
Fucan Xia
Yidong Zhu
Bo Chen
Cell Communication and Signaling, 21
[44] A Novel, Oral, Allosteric Inhibitor of Tyrosine Kinase 2 (TYK2) Demonstrates In Vitro Potency, Selectivity, and In Vivo Efficacy in Mouse Models of Psoriasis
Hussein, Razika
Tsuruda, Pamela
Mortezaei, Shahab
Ferdyan, Nicky
Wegerski, Christopher
Srinivasan, Karthik
Hirst, Gavin
Mozaffarian, Neelufar
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1848 - 1849
[45] Transcriptome analysis reveals a major impact of JAK protein tyrosine kinase 2 (Tyk2) on the expression of interferon-responsive and metabolic genes
Vogl, Claus
Flatt, Thomas
Fuhrmann, Bernd
Hofmann, Elisabeth
Wallner, Barbara
Stiefvater, Rita
Kovarik, Pavel
Strobl, Birgit
Mueller, Mathias
BMC GENOMICS, 2010, 11
[46] The significance of tyrosine kinase 2 gene in encephalomyocarditis-D virus-induced diabetes as studied in Tyk2 gene knockout mice
Nagafuchi, Seiho
Teshima, Miho
Kai, Yuji
Kai, Katsuya
Izumi, Kenichi
Kurisaki, Hironori
Katsuta, Hitoshi
Nagafuchi, Seiho
JOURNAL OF IMMUNOLOGY, 2013, 190
[47] A novel highly selective allosteric inhibitor of tyrosine kinase 2 (TYK2) can block inflammation- and autoimmune-related pathways
Chen, Celia X. -J.
Zhang, Wei
Qu, Shulan
Xia, Fucan
Zhu, Yidong
Chen, Bo
CELL COMMUNICATION AND SIGNALING, 2023, 21 (01)
[48] A comparative proteome analysis links tyrosine kinase 2 (Tyk2) to the regulation of cellular glucose and lipid metabolism in response to poly(I:C)
Grunert, Toni
Leitner, Nicole R.
Marchetti-Deschmann, Martina
Miller, Ingrid
Wallner, Barbara
Radwan, Marta
Vogl, Claus
Kolbe, Thomas
Kratky, Dagmar
Gemeiner, Manfred
Allmaier, Guenter
Mueller, Mathias
Strobl, Birgit
JOURNAL OF PROTEOMICS, 2011, 74 (12) : 2866 - 2880
[49] Transcriptome analysis reveals a major impact of JAK protein tyrosine kinase 2 (Tyk2) on the expression of interferon-responsive and metabolic genes
Claus Vogl
Thomas Flatt
Bernd Fuhrmann
Elisabeth Hofmann
Barbara Wallner
Rita Stiefvater
Pavel Kovarik
Birgit Strobl
Mathias Müller
BMC Genomics, 11
[50] Exposure-efficacy response modelling of bms-986165, a selective oral tyrosine kinase 2 (TYK2) inhibitor, in a phase 2 study in psoriasis
Girgis, I.
Chimalakonda, A.
Kundu, S.
Throup, J.
Banerjee, S.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 36 - 36

← 1 2 3 4 5 →